This year’s flu season is shaping up to be a nasty one—driven by a new variant of the influenza virus that may be able to slip past our vaccine defenses. A mutated form of the influenza A strain H3N2 ...

At least 14 states and Washington, DC, are reporting high or very high flu activity. The dominant flu strain, a version of influenza A (H3N2) called subclade K, has multiple mutations that make it ...

Doctors and scientists say this year's influenza season could be tougher than usual. A new version of the flu virus, called H3N2, is spreading quickly. At the same time, fewer people are getting flu ...

Still, while some Midwest states are seeing a "high" number of influenza cases, according to recent data from the Centers for Disease Control and Prevention, Illinois cases remain "minimal." The ...

(NEXSTAR) – Cases of the flu continue to mount, with health officials recently recording the first pediatric flu-related deaths of the season, but some states are seeing much higher activity than ...

As Christmas travel accelerates, health authorities in the US, Canada and the UK are tracking a fast-spreading super flu virus that is driving a sharp rise in influenza cases. The strain, known as ...

Flu season is among us, and a new strain has emerged as a major threat. A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising global cases, including in the U.S ...

(NEXSTAR) – As we get deeper into flu season, a new type of the influenza virus has been identified, the Centers for Disease Control and Prevention confirms. The new strain is a variation of influenza ...

DNA scaffolds that mirror influenza virus protein geometry boost antiviral binding and reduce infection more effectively than free molecules, enabling a modular antiviral design strategy. (Nanowerk ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Flu vaccines that take a page from the COVID-19 vaccine platform are making progress in clinical trials. In a phase 3 trial, Pfizer’s mRNA flu vaccine outperformed a traditional vaccine, researchers ...

FILE - This undated electron microscopic image provided by the Centers for Disease Control and Prevention shows two Influenza A (H5N1) virions, a type of bird flu virus. (Cynthia Goldsmith, Jackie ...